Leading with Science and Heart: Building a Resilient Biotech
In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Dr. Ross Breckenridge, CEO of Arjuna Therapeutics, a company pioneering a novel approach to precision oncology through therapeutic molecular clusters. Dr. Breckenridge shares insights on the cultural differences between academia and industry, the benefits of conducting clinical trials in Europe over the U.S., and the importance of chemistry manufacturing controls (CMC) in drug development. He also discusses the challenges of raising capital and the critical role of strong leadership to build and foster a resilient and reliable team.
Related Insights
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025